Skip to main content

Table 2 Distribution of LTRs in Active promoters in malignant, immortalized, primary and embryonic stem cells.

From: VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer

  Cell Type Total Promoters Total Promoters that overlap LTRs % of Total Promoters that overlap LTRs Cell-line Specific Promoters % Cell-line Specific Promoters Cell-line Specific Promoters that overlap LTRs % of Cell line Specific Promoters that overlap LTRs Number of LTRs that overlaps cell-line specific Promoters
K562 Malignant 15,627 1,199 7.7% 1,599 10.2% 427 26.7% 622
HepG2 Malignant 15,993 1,165 7.3% 1,886 11.8% 303 16.1% 400
GM12878 Immortalized 15,279 989 6.5% 1,613 10.6% 153 9.5% 203
NHLF Primary 14,888 546 3.7% 259 1.7% 15 5.8% 16
HMEC Primary 13,711 535 3.9% 145 1.1% 9 6.2% 12
HSMM Primary 14,335 537 3.7% 305 2.1% 23 7.5% 25
HUVEC Primary 12,319 397 3.2% 102 0.8% 6 5.9% 7
NHEK Primary 14,009 700 5.0% 219 1.6% 24 11.0% 29
H1-hESC Embryonic Stem 12,477 568 4.6% 453 3.6% 217 47.9% 308